LARGE-CELL LYMPHOMA
Clinical trials for LARGE-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new LARGE-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for LARGE-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells show promise against tough childhood cancers
Disease control CompletedThis study tested a new treatment for children and young adults (ages 1-39) with B-cell leukemia or lymphoma that did not respond to standard therapy. The treatment involved taking a patient's own white blood cells, modifying them in a lab to target the CD22 protein on cancer cel…
Matched conditions: LARGE-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New drug combo may make Half-Matched transplants safer for blood cancer patients
Disease control CompletedThis study tested whether replacing a standard transplant drug (cyclophosphamide) with a different drug (bendamustine) could make half-matched bone marrow transplants safer for people with blood cancers like leukemia and lymphoma. About 50 patients took part. The goal was to redu…
Matched conditions: LARGE-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: University of Arizona • Aim: Disease control
Last updated May 01, 2026 15:57 UTC